What is the typical duration of paroxetine discontinuation syndrome after cessation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Paroxetine Withdrawal Symptoms

Paroxetine withdrawal symptoms typically begin within 24-48 hours of discontinuation, peak around day 5, and usually resolve within 2-3 weeks, though symptoms can persist for up to 4 weeks or longer in some cases, particularly with abrupt cessation or prolonged use. 1, 2

Typical Timeline of Withdrawal Symptoms

Onset and Peak

  • Symptoms generally begin within 1-3 days after the last dose or dose reduction 3, 2
  • Maximum symptom intensity occurs around day 5 after discontinuation 2
  • In neonates exposed to paroxetine in utero, symptoms can appear within hours to days after birth 1

Resolution Period

  • Most withdrawal symptoms resolve within 2-3 weeks in the majority of patients 2, 4
  • The mean duration of symptoms in one study was 11.8 days, with symptoms persisting up to 21 days 4
  • In neonatal cases, symptoms typically resolve within 1-2 weeks, though one infant exposed to paroxetine had persistent signs through 4 weeks of age 1

Factors That Prolong Withdrawal Duration

High-Risk Scenarios for Extended Symptoms

  • Abrupt discontinuation rather than gradual tapering significantly increases both severity and duration 5, 2
  • Longer treatment duration: Patients treated for a median of 28 weeks experienced more withdrawal symptoms compared to those treated for 16 weeks 4
  • Higher daily doses: Intensity and duration correlate with the dose being discontinued 2, 6
  • Paroxetine's short half-life makes it particularly prone to withdrawal compared to longer half-life SSRIs like fluoxetine 3, 4

Prolonged or Atypical Cases

  • In a study of panic disorder patients undergoing gradual tapering, 45% experienced discontinuation syndrome, with symptoms persisting for months in three patients who had been taking paroxetine long-term 7
  • Late onset and longer persistence of disturbances are possible variations from the typical pattern 8

Clinical Implications

Symptom Characteristics

  • Common symptoms include dizziness, vertigo, sensory disturbances (paresthesias, "electric shock" sensations), nausea, headache, lethargy, anxiety, irritability, insomnia, and vivid dreams 5, 3, 2, 4
  • Symptoms are rapidly relieved within 24 hours by reintroducing the medication 4
  • Benzodiazepines do not relieve these withdrawal symptoms 4

Prevention Strategy

  • Gradual tapering over several weeks to months is essential, reducing by the smallest increment possible (e.g., 2.5 mg steps) with at least 1-2 weeks between reductions 5, 3
  • Even with slow tapering, withdrawal symptoms can still occur but are generally less severe and shorter in duration 7

Critical Pitfall

  • Do not mistake withdrawal symptoms for relapse of the underlying condition - this misdiagnosis can lead to unnecessary long-term medication continuation 5, 8
  • Withdrawal symptoms typically have a distinct temporal relationship to dose reduction and include physical symptoms (dizziness, paresthesias) not characteristic of depression recurrence 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Paroxetine withdrawal syndrome].

Annales de medecine interne, 2000

Guideline

Management of SSRI Withdrawal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Serotonin reuptake inhibitor withdrawal.

Journal of clinical psychopharmacology, 1996

Guideline

Tapering and Discontinuing Paroxetine 10 mg

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Which selective serotonin reuptake inhibitors (SSRIs), such as Paxil (paroxetine) or Prozac (fluoxetine), are difficult for patients to wean off and discontinue use?
How do we treat patients with brain zaps due to paroxetine (Paxil) discontinuation?
For a 58‑year‑old male with normal labs who discontinued paroxetine (Paxil) 40 mg daily and now has worsening depression, how should his antidepressant therapy be managed?
Can a patient experience Selective Serotonin Reuptake Inhibitor (SSRI) withdrawal for 3 months or longer after stopping or tapering off medication?
Can stopping Zoloft (sertraline) cause dizziness and nausea in a patient?
Should amlodipine be discontinued in a patient who develops acute kidney injury?
Can daily 5 mg tadalafil improve erectile function in an older man with benign prostatic hyperplasia who has no history of priapism, is not taking nitrates, and has stable cardiovascular status?
According to the national malaria management guideline, how should a patient with fever who has been in a malaria‑endemic area be screened and treated for uncomplicated Plasmodium falciparum infection, severe malaria, and malaria in pregnancy, including the recommended drug regimens and dosing?
Are antihistamines contraindicated during pregnancy?
What is the pathophysiology of rectal sexual arousal (inner rectal arousal) triggered by thoughts, anticipation, or light activity such as walking?
How should I treat a patient with a partial pressure of arterial oxygen of 60 mm Hg, bicarbonate of 28 mmol/L, and oxygen saturation of 89%?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.